Teva Pharmaceutical Industries News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.07.15	Teva To Buy Allergan Generics For $40.5 Bln Cash, Stock; Shares Up (RTTNews)
27.07.15	Teva Reports Q2 EPS Of $1.43, Lifts FY Earnings Outlook; Stock Up In Pre-market (RTTNews)
27.07.15	Teva To Buy Allergan Generics For $40.5 Bln; Withdraws Offer For Mylan (RTTNews)
27.07.15	Allergan To Acquire Naurex For $560 Mln In Cash (RTTNews)
26.07.15	WSJ: Teva In Talks To Buy Allergan's Generic Drug Unit For About $45 Bln (RTTNews)
23.07.15	Mylan Foundation Exercises Call Option To Buy 488.39 Mln Mylan Preferred Shares (RTTNews)
13.07.15	ANI Pharmaceuticals Acquires 22 Generic Drug Products From Teva For $25 Mln (RTTNews)
07.07.15	AstraZeneca, Teva's Cephalon Settle Allegations Of Underpaying Medicaid Rebates (RTTNews)
07.07.15	Teva Reportedly Plans To Raise Mylan Bid By As Much As $2 Bln (RTTNews)
01.07.15	Teva Launches Generic Aggrenox Capsules In U.S. - Quick Facts (RTTNews)
01.07.15	Teva Says TV-45070 Phase 2b Results Did Not Indicate Efficacy In Osteoarthritis (RTTNews)
19.06.15	Teva Completes Purchase Of 4.61% Stake In Mylan - Quick Facts (RTTNews)
19.06.15	Novartis' Sandoz Launches Generic Version Of Teva's Copaxone In U.S. (RTTNews)
18.06.15	Momenta : CAFC Invalidates Remanded Teva Patent In Daily Copaxone 20 Mg Suit (RTTNews)
18.06.15	Teva Reports Data From Addl Analyses Of Phase 2b Studies In Migraine Prevention (RTTNews)
17.06.15	So Long, KYTHERA (RTTNews)
16.06.15	Abbott Laboratories To Vote In Favor Of Myan's Takeover Bid For Perrigo (RTTNews)
16.06.15	Teva Pharma: ARM-TD Study With SD-809 Meets Primary Endpoint (RTTNews)
15.06.15	FDA Accepts For Review Teva's BLA For Reslizumab - Quick Facts (RTTNews)
09.06.15	Teva Says Committed To Mylan Takeover (RTTNews)
02.06.15	Teva Launches Generic Equivalent To INTUNIV In The United States - Quick Facts (RTTNews)
02.06.15	Mylan Believes Teva's Acquisition Of Mylan Shares Violates U.S. Antitrust Laws (RTTNews)
01.06.15	Teva Announces Launch Of Generic Equivalent Of Actonel For Osteoporosis In U.S. (RTTNews)
01.06.15	Researchers Evolve 'Gamechanger' Immunotherapy For Cancer Treatment (RTTNews)
29.05.15	Teva Pharma Launches Generic Lomedia 24 Fe Tablets - Quick Facts (RTTNews)
14.05.15	Teva Presents Further Data From PhaseIIb With TEV-48125 In Chronic Migraine (RTTNews)
14.05.15	CORT For The Long Haul, RVNC Has No Reason To Frown, MSLI Swings To Profit (RTTNews)
13.05.15	ANI Pharma Acquires Approved NDA For Testosterone Gel 1% From Teva - Quick Facts (RTTNews)
12.05.15	Mylan Chairman To Consider Perrigo Sweeteners To Make Deal : Bloomberg (RTTNews)
05.05.15	Teva Says Ready And Willing To Meet With Mylan On Proposed Combination (RTTNews)
01.05.15	MDCO Gets FDA Nod For 2 Products, EXEL Awaits METEOR Data, WX To Make History (RTTNews)
30.04.15	Pre-market Movers For April 30 (XOM, CI, TEVA, CRM, GLUU, CKSW, POT, CELG, OVTI) (RTTNews)
30.04.15	Teva Q1 Profit Down; But Raises 2015 EPS View - Quick Facts (RTTNews)
29.04.15	Teva Reiterates Offer To Buy Mylan (RTTNews)
29.04.15	Perrigo Again Rejects Mylan Offer - Quick Facts (RTTNews)
29.04.15	FDA Approves First Generic Abilify To Treat Mental Illnesses (RTTNews)
28.04.15	CRY Has A Reason To Smile, MDXG Lifts Outlook, MYL Rejects Teva Bid (RTTNews)
27.04.15	Mylan Spurns Teva's $40 Bln. Offer - Update (RTTNews)
27.04.15	Teva Reiterates Its Commitment To Proposed Combination With Mylan - Quick Facts (RTTNews)
27.04.15	Mylan Rejects Buyout Bid By Teva; Remains Committed To Firm Offer For Perrigo (RTTNews)
24.04.15	Mylan To Commence Formal Offer To Acquire Perrigo - Quick Facts (RTTNews)
22.04.15	Teva Files For HSR Notification Regarding Proposed Mylan Acquisition (RTTNews)
21.04.15	Mylan Surges On Teva's $40 Bln. Offer (RTTNews)
21.04.15	Teva Announces Proposal To Acquire Mylan In Cash And Stock Deal - Quick Facts (RTTNews)
21.04.15	Teva Considers Making Offer For Mylan : Report (RTTNews)
17.04.15	SSH Shines, First Generic MS Drug Approved, MNOV On Fast Track, ALDX On Watch (RTTNews)
17.04.15	Sandoz : FDA Approves First Generic Copaxone To Treat Multiple Sclerosis (RTTNews)
16.04.15	Ovid Therapeutics Names Jeremy Levin CEO - Quick Facts (RTTNews)
16.04.15	Celsion Warms Up, AMGN Gets FDA Nod, SKBI Put On Notice, VVUS Sues Teva (RTTNews)
16.04.15	VIVUS Files Lawsuit Against Teva For Infringement Of Qsymia Patents (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Handel in Europa: STOXX 50 schliesst im Minus
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Minuszeichen in London: FTSE 100 schwächelt zum Ende des Freitagshandels
20.12.24		Handel in Zürich: SMI verbucht Verluste
20.12.24		Anleger in London halten sich zurück: So bewegt sich der FTSE 100 aktuell

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Handel in Europa: STOXX 50 schliesst im Minus

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

Minuszeichen in London: FTSE 100 schwächelt zum Ende des Freitagshandels